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ABSTRACT: In this study, we report, for the ﬁrst time, the
synthesis of two original nanosystems, based on gold Au(III) and
copper Cu(II): simple gold−copper nanoparticles (Cu0AuNPs)
and enriched monopicolinate cyclam (L1)−Cu(II)−Au(III)-
complex (L1@Cu2+AuNPs). The two nanomaterials diﬀer
substantially by the chelation or not of the Cu(II) ions during
the NPs synthesis process. The two hybrid nanoparticles
(Cu0AuNPs; L1@Cu2+AuNPs) were deeply studied from the
chemical and physical point of view, using many diﬀerent
analytical techniques such as Raman and UV−vis spectroscopy,
electron transmission microscopy, and dynamic light scattering.
Both nanosystems show morphological and good chemical
stability at pH 4 values and in physiological conditions during 98
h. Undiﬀerentiated and neural diﬀerentiated murine embryonic stem cells were used as a model system for in vitro experiments
to reveal the eﬀects of NPs on these cells. The comparative study between Cu0AuNPs and L1@Cu2+AuNPs highlights that
copper chelated in its +2 oxidation state in the NPs is more functional for biological application.
1. INTRODUCTION
Hybrid metal−organic nanoparticles (NPs) have been recently
used as diagnostic and therapeutic tools to better understand,
detect, and treat several human diseases.1,2 Metal-based NPs
have been proposed as performing contrast agents that can
increase signal intensity in magnetic resonance imaging (MRI)
and positron emission tomography imaging, or as nanovectors
for speciﬁcally delivering of drugs inside cells.
The insertion of copper (Cu), especially as Cu2+ atoms, in
NPs structures is still challenging because it has an important
impact in many scientiﬁc ﬁelds from catalysis and plasmonics
up to nanomedicine applications.3−6 Because cationic metals
take part in biological systems (charge balancing, stabilizing
structures, reactions catalyzing, and so on), copper ions should
be chelated to avoid the in vivo metal releasing that could
induce several undesirable eﬀects.
Biocompatible copper(II) chelators are commonly those
that yield thermodynamically stable and kinetically inert
complexes so that transchelation of Cu due to competition
with other biological ligands, metals, or reductive media is
avoided. Among known copper(II) ligands, azacycloalkanes
present the highest complexion properties.7 By N-functional-
ization of their properties, especially in terms of kinetic of
formation (maximizing the complexation rate) and dissociation
(decreasing of the decomplexation rate), could also be
improved. A special category of rigid tetraazamacrocycles,
indicated as cross-bridged derivatives, has been the source of
great interest because of the outstanding behavior in
complexing diﬀerent metals, including copper(II).8−10 Due
to an ethylene linker connecting two opposite nitrogen atoms
of the macrocycle, these ligands produced some of the most
inert metal complexes ever reported.
We recently have published a size-adapted azamacrocycle,
the cb-te1pa chelator11−13 (see its structure in Figure 1), which
combines all the criteria for Cu(II) chelation, i.e., the presence
of cyclam, the ethylene cross bridge and an eﬃcient chelating
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functionalization, in particular the methyl pycolinic acid, a
cross-bridged cyclam bearing a methylpycolinate pendant. This
compound was able to chelate copper(II) after fast complex-
ation, yielding a highly thermodynamical stable and an
exceptionally inert product, even if Cu was in the (+1)
oxidation state. Due to the presence of a secondary amine, an
additional functional group, which could be dedicated to the
conjugation of cb-te1pa with a solid support, was then easily
added as an aniline moiety. To preserve a suﬃcient distance
between the coordination center and the anchoring point, an
ethylene linker was chosen to take away the aromatic part. The
bifunctionalized analogue cb-te1pa-EtpPhNH2 (L1) was then
the ﬁnal Cu ligand (Figure 1).
In the present study, we synthesized two new nanoparticle
systems including gold and copper wrapped in their structure.
In the ﬁrst case, Cu(II) was introduced as “free” cation and in
the second case, in its [Cu(cb-te1pa)]+-EtpPhNH2 chelated
form (L1Cu+). According to the NPs formation procedure, the
ﬁrst material included Cu0, whereas the second one the Cu2+
chelated ions. Characterizations were performed to investigate
the structure of both NPs. Potential cytotoxic eﬀects was
evaluated in vitro on undiﬀerentiated and neural diﬀerentiated
embryonic stem cells (ESCs). ESCs can be used as a model
system in basic research, drug discovery, biomedical
applications, and nanotechnology because they combine the
potential of unlimited self-renewal with the ability to
diﬀerentiate into a wide range of tissue-speciﬁc cells.
2. RESULTS AND DISCUSSION
2.1. Formation Mechanisms of Au−Cu-Based Nano-
particles. Peculiar molecular interactions between organic
compounds and metal chlorides was extensively studied for
many biochemical and physical applications.19−22 The aim of
this study was to use a copper−gold chloride blend as the
building blocks of hybrid nanoparticles under speciﬁc
conditions of reaction. For this purpose, in the ﬁrst step, we
mixed HAuCl4·3H2O and CuCl2·6H2O in water solution at
room temperature under speciﬁc pH conditions (Scheme 1).
The formation of Au−Cu blend (Figure S1 in the Supporting
Information) could be deduced by looking at the ﬁngerprints
of each single solution (HAuCl4·3H2O, CuCl2·6H2O) present
in the UV−vis spectrum of their mix (Au−Cu). In particular,
the UV−vis spectrum of HAuCl4·3H2O (black line in Figure
S1) showed typical signatures with two prominent peaks at 256
and 290 nm. The UV−vis spectrum of CuCl2·6H2O solution
showed a peak at 256 nm, a small peak at 280 nm and a
broadened peak at 800 nm (red line in Figure S1). When
CuCl2·6H2O was added to HAuCl4·3H2O solution, the UV−
vis spectrum (blue line in Figure S1) slightly changed. Main
diﬀerence in the spectra was due to the increase and the shift
of the peak from 280 to 320 nm due to electronic transitions.
Moreover, the dramatic decrease of the peak at 800 nm
conﬁrmed that the hybrid system (Au−Cu) was obtained.20
Raman spectroscopy (Figure S1B) also displayed the peak at
254 cm−1 due to Cu−Au−Cl and Cu−OH stretching, which
were assigned to vibrations mainly within the coordination
sphere of Cu2+, conﬁrming the successful reaction.20
Figure S2a,b in the Supporting Information shows the
localized surface plasmon (LSP) resonance spectra before and
after incubation of HAuCl4 mixed to CuCl2 under speciﬁc
conditions (pH: 4.0−7.0−9.0; time: 96 h). At pH 4, we
observed an increase in the peak intensity at 256 nm probably
due to CuCl2 ﬁngerprint associated to AuCl2 ions upon
complexation. The increase of the peak at 800 nm conﬁrmed
the reaction under acidic conditions. A diﬀerent behavior was
observed in the case of pH 7 and pH 9 (Figure S2 panel b), in
which the LSP bands could not be observed any more after
incubation at pH 7 and 9 for 96 h. This spectroscopic behavior
during pH release gave evidence of the change of reagent
conformation when it was encapsulated into gold nano-
particles.
2.2. Formation Mechanism of Cu0−AuNPs and L1@
Cu2+−AuNPs. Recently, Spadavecchia et al. have designed and
produced diﬀerent novel hybrid nanomaterials based on gold,
polymers, proteins, and drug complexes by original chemical
synthetic methodology.17,23,24 These authors have investigated
the formation mechanism and the competition eﬀect between
various capping agents on the growth process of hybrid
nanoparticles.25 Some chemical−physical characterizations and
the analysis of biological activity have fully elucidate that
conformation change of biomolecules (i.e., polymer, drug,
protein) during the formation of hybrid gold nanostructures by
chelation had a good impact on its therapeutic activity. In case
of Cu, other authors showed that copper inﬂuenced the optical
plasmonic features of the gold nanorods when incorporated in
Figure 1. Ligand cb-te1pa and its bifunctionalized analogue cb-te1pa-
EtpPhNH2.
Scheme 1. Schematic Representation of the Hybrid Blend (Au−Cu)
aPlease note that drawings are not in scale and are not intended to be representative of the full samples composition.
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the growth solution during the seed-mediated synthesis.4 The
aim of this research was to prove the formation of stable hybrid
complexes based on PEGylated Au−Cu and PEGylated L1@
Au−Cu, respectively. Some synthesis procedures of
Cu2+AuNPs by chemical and physical adsorption using
chelator linkers can be found in recent literature.19,26 The
main diﬀerence with previously reported synthetic procedures
was that L1 ligand totally bound Cu2+ and participated in the
stabilization of PEGylated Cu2+−AuNPs via electrostatic
interaction between their amino groups with chloride
copper−auric ions. Moreover, the chelation of Cu2+ avoided
its reduction during the NPs synthesis process. Indeed, the
macrocyclic chelation added extremely high stability to the
copper(I) complex and allowed the stability of the chelate all
along the formation of the ﬁnal material.
The formation of hybrid gold−copper NPs from Cu−Au
mixture is summarized in Schemes 2 and 3. Step (1) was the
complexation of solutions CuCl2−AuCl4− and generation of
copper−gold clusters (see Scheme 2). Step (2) is the initial
reduction of Au(III) ions by dicarboxylic acid-terminated
poly(ethylene glycol) (PEG) that adsorbed onto Cu−Au
clusters (Scheme 2); the last step (3) is the reduction of metal
ions in that vicinity and the growth of hybrid gold particles
(Cu0−AuNPs) together with the colloidal stabilization due to
the molecules of PEG polymers.
In this frame, L1 ligands take part in the reaction, thanks to
their amino group onto copper−gold clusters in which copper
was kept in oxidation state Cu2+ and chelated with them
(Scheme 3). The positive charge of the amino group onto L1
ligand in water solutions showed strong electrostatic
interaction with negatively charged Cu2+−AuCl ions and
formed a complex L1@Cu2+−AuCl that played a ﬁnal role in
the growth of NPs. A large excess of L1 ligand in the mixture
was required to chelate completely all Cu2+. The addition of
diacid PEG improved the kinetics of reduction by complex-
ation of Cu−Au ions,27,25 just tuning the growth process of
hybrid nanoparticles. During the S2 phase (Scheme 3), L1@
Cu2+−AuCl complexes migrated through PEG molecules.
Thus, an appreciable amount of complexes diﬀused and were
captured inside the PEG layer via a mechanism similar to the
other ligand complexes loaded onto nanostructures.16,23,28
Based on previously research studies,29 we suppose that when
PEG was added to the L1@Cu2+−AuCl, the PEG initially was
bound to hybrid complex in a mushroom conformation
Scheme 2. Schematic Representation of the Synthesis of Cu0−AuNPs via a Two-Step Processa
aPlease note that drawings are not in scale and are not intended to be representative of the full samples composition.
Scheme 3. Schematic Representation of the Synthesis of L1@Cu2+−AuNPs via a Three-Step Processa
aPlease note that drawings are not in scale and are not intended to be representative of the full samples composition.
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followed by a conformational change to brush mode.15,17 The
ﬁnal reduction by NaBH4 completed the grow process to form
L1@Cu2+−AuNPs. All products of our synthetic procedure
were characterized by UV−vis absorption spectroscopy,
transmission electron microscopy (TEM), and Raman spec-
troscopy.
2.3. Comparative Physicochemical Characterization
of Cu0−AuNPs and L1@Cu2+−AuNPs. TEM images of
Cu0−AuNPs showed a well dispersion of the nanoparticles
with an average size of 20 ± 1 nm (Figure 2A overpanel).
Diﬀerent nanostructures were obtained with L1@Cu2+−
AuNPs: they exhibited a nanocapsule-like shape embedded
in a shell of PEG, in which metal nanoparticles showed a
diameter of around 28 ± 2 nm (Figure 2A underpanel). The
synthesis of Au/Cu alloy nanoparticles using biocompatible
liquid polymer22 and the fabrication of snowﬂakes nano-
particles by catalytic CO oxidation11 have been already
reported. Anyway, a study about the grafting of L1 ligands
onto Cu0−AuNPs has not been reported. When L1 ligands
were added to the Cu2+−AuCl solution, the picolinate amino
group was initially electrostatically bound to Au−Cu clusters,
followed by a conformational change of the ligand L1 that
chelated Cu2+ ions completely and successively embedded in
the dicarboxylic PEG in a mushroom conformation.15
Figure 2B black line reports the absorption spectra of hybrid
Cu0−AuNPs, all characterized by a surface plasmon band in
the range of 560 nm, together with a small peak at 775 nm.
The slow shift of the band position depended on the ratio of
the gold salt and the capping materials during the reaction
processes.30,31 This peak could be generally ascribed to
collective oscillation, known as the surface plasmon oscillation
of the metal electrons in the conduction band, due to
interaction of electrons with light of a certain wavelength. PEG
could be used as a stabilizing polymer for AuNPs because the
dispersed solutions could be obtained due to the formation of
coordination bands between Au and Cu ions with the
carboxylic group. The chelation eﬀect even better dispersed
Au and Cu ions, which were reduced to form single Cu0−
AuNPs of relatively uniform size. Figure 2B red line displays a
UV−vis an absorption spectrum of L1@Cu2+−Au NPs.
Compared with Cu0−AuNPs spectrum, a blue shift of the
plasmon peak from 560 to 535 nm and a red shift of the peak
at 775−810 nm could be observed. The latter was associated
to π−π* electronic transitions due to interactions between the
L1 ring and CuAuCl2 ions and gave a clear evidence of the
complex formation with a change of color of the colloidal
solution from pink red (Cu0−AuNPs) to bright violet (L1@
Cu2+−Au NPs).
The NP sizes were conﬁrmed by dynamic light scattering
(DLS) measurements (Table 1). ζ-Potential measurements
showed that Cu0−AuNPs and L1@Cu2+−AuNPs were stable
colloids at physiological pH (ζ-potential = −25 ± 3 and −20 ±
2 mV with a PdI equal to 0.3) (Table 1). This stability was
enhanced by the presence of the PEG layer around
nanoparticles.25
Raman spectra of Cu0−AuNPs exhibited many bands in the
region 500−2000 cm−1 (Figure 3C black line). The wide band
observed around 1600 cm−1 on the Raman spectra was
assigned to the water. The strong band at 1712 cm−1 was
assigned to CO carbonyl stretching of PEG diacid. The
intense doublet at 720−760 cm−1 was due to the C−H plane
deformation and a strong peak at 1439 cm−1 was assigned to
νC−C stretching. These bands were due to the variation of the
steric conformation of the PEG diacide and became more
Figure 2. (A, A′) TEM images of Cu0−AuNPs (panel A) and L1@Cu2+−AuNPs (panel A′). (B) Normalized UV−vis absorption and scale bars: 50
and 20 nm for Cu−AuNPs and 0.2 μm and 100 nm for L1@Cu2+−AuNPs and CuCl2·6H2O as control. (C) Raman spectra of Cu−AuNPs and
L1@Cu2+−AuNPs products compared to free L1 and CuCl2·6H2O as control. Raman spectra. Experimental conditions: λexc = 785 nm; laser power
20 mW; accumulation time 180 s.
Table 1. ζ-Potential and Hydrodynamic Diameter of Cu0−
AuNPs and L1@Cu2+−AuNPs
synthetic product
ζ-potential
(mV)
hydrodynamic diameter
(nm) PdI
Cu0−AuNPs −25 ± 3 20 ± 2 0.3
L1@Cu2+−AuNPs −20 ± 2 28 ± 2 0.3
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prominent upon complexation with Cu−AuCl2, as previously
described.16,20 As matter of fact, when CO and hydroxyl
groups of PEG diacide interacted with a metal, the sterical
conformation became more tilted with respect to the planar
one. Focusing on the spectral range 200−500 cm−1 (Figure
2C), we can observe several spectral changes, which conﬁrmed
a chemical modiﬁcation of Cu after complexation with gold
ions and PEG diacide molecules. One of the Raman ﬁngerprint
of the Cu−PEG−AuNPs was the presence of a band around
263 cm−1, and a double peak at 235−285 cm−1 was observed.
These bands could be assigned to the gold chloride stretches,
ν(Au−Cl), and δ(O−Au−O) and δ(Cu−Au−O) are a clear
evidence of the formation of a complex between AuCl2
− and
Cu and PEG diacide in the solution. The peak at 430 cm−1 was
due to the vibrations δ(OH···O), ν(OH···O) of the PEG, as
previously described.15,16 The bands in the region 3000 cm−1
could be assigned to the aromatic C−H stretching (Figure
2C). A broad band composed of some peaks appeared in the
spectral range 2850−2930 due to the symmetric CH2−CH3
stretch vibration of PEG diacide molecules, conﬁrming the
main role of the polymer in the synthesis of the nanoparticle.
The steric arrangement of L1 ligand during the synthesis
process of PEGylated copper−gold nanoparticles was con-
ﬁrmed by Raman spectroscopic analysis (Figure 2C).
Raman spectra of free L1@Cu2+−AuNPs in water showed
SERS eﬀect in the range 300−1800 cm−1. The spectral
modiﬁcations were evidence of the steric conformational
change of the L1 after grafting on the copper−gold
nanoparticles. One of the Raman ﬁngerprints of the L1@
Cu2+−AuNPs was the presence of a band around 340 cm−1
due to the copper(II) peroxide complex, where L1 chelates
Cu2+. The common peak at 450 cm−1 was due to the vibrations
δ(OH···O), ν(OH···O) of the PEG as previously de-
scribed.15,16 On the basis of the spectrochemical and
previously theoretical ﬁndings, we assumed that Au3+ ions
promoted the deprotonation of the L1 amino group. These
bands were due to variation of the steric conformation of the
L1 and became more prominent upon electrostatic interaction
with gold cluster and then chelation with Cu2+.
2.4. Cytotoxicity of Cu0−AuNPs and L1@Cu2+−
AuNPs. Murine ES cells and neural-derived ES cells were
exposed to Cu0−AuNPs and L1@Cu2+−AuNPs nanoparticles
at diﬀerent concentrations (0−1000 nM) for 24 h (Figure 3),
and cytotoxicity was analyzed by live−dead staining, and LC50
was calculated. At maximum used concentration (10 μM),
both kinds of nanoparticles determined the death of almost all
the cells. They resulted not cytotoxic for concentrations up to
100 nM, suggesting a fair good biocompatibility at this
concentration. However, the NPs were found to display
signiﬁcant cytotoxicity still at the concentration of 250 nM.
The nanoparticles showed concentration-dependent cytotox-
icity in both cells: the neural-derived ES cells were more
sensitive toward the toxicity of both particles than the
undiﬀerentiated ES cells. The results highlight the diﬀerence
of cytotoxicity between nanoparticles used and diﬀerential
sensitivity of cells to Cu0−AuNPs or L1@Cu2−AuNPs.
However, the toxic response varied depending on the type of
cell exposed due to diﬀerential sensitivity.
The results obtained on ES cells were used to identify the
range of NPs concentrations to test the cytotoxicity on neural-
derived ES cells. These cells were exposed to the same
concentration of Cu0−AuNPs and L1@Cu2+−AuNPs, i.e., 0−
100−250−1000 nM, for 24 h. The 50% of lethal dose for both
NPs, reported in Table 2, was determined using trypan blue
dye exclusion.
On neural-derived ES cells, the Cu0−AuNPs were more
toxic, with LD50 value of 600 nM, than the L1@Cu2+−AuNPs
nanoparticles, with LD50 value of 950 nM. Light microscopy
analysis characterized the eﬀect of diﬀerent concentrations of
NPs on neural-derived ES cells morphology. Even at 100 nM,
both NPs preserved the cell viability and morphology, with
quite equal toxicity proﬁle observed for both NPs; at 250 nM,
neural-derived ES cells treated with L1@Cu2+−Au NPs
exhibited more neurite reduction than those treated with
Cu0−AuNPs. At 1000 nM of both NPs, the cells appeared to
refract the light, suggesting a typical apoptotic phenotype
(Figure 4).
2.5. Determination of Cellular Uptake of NPs by
Confocal Microscopy. The neural-derived ES cells were
plated on a gelatin-coated microscope slide and left to adhere
overnight before adding Cu0−AuNPs and L1@Cu2+−AuNPs
labeled with the ﬂuorophore at 200 nM, a concentration well
below the LD50 for both kinds of NPs. As shown in Figure 5,
Figure 3. Cytotoxicity of ES cells incubated with diﬀerent
concentrations of Cu0−AuNPs or L1@Cu2−AuNPs nanoparticles
(0−10 μM) for 24 h. Bar = 50 μm.
Table 2. LD50 of Neural-Derived ES Cells after 24 h of
Treatment with Cu0−AuNPs or L1@Cu2+−AuNPs
Nanoparticles
LD50% (nM) LD50% (μg/mL)
Cu0−AuNPs 600 0.16
L1@Cu2+−AuNPs 950 0.25
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both NPs synthetized were internalized into neural-derived ES
cells but with some qualitative diﬀerences. Confocal images
showed Cu0−AuNPs internalized more than L1@Cu2+−
AuNPs. Moreover, even if slightly larger, the Cu0−AuNPs
were internalized also inside the nucleus. This capability may
be caused by a more eﬃcient interaction with mammalian cell
membranes.
Confocal images conﬁrmed that NPs were mainly located
within the cell and not adhered to the cell surface: the
ﬂuorescent signal of Cu0−AuNPs was predominantly observed
in the cytoplasm and also in the nuclei; on the contrary, the
ﬂuorescent signal of L1@Cu2+−AuNPs was prevalently present
in the cytoplasm (Figure 5).
From data collected in biological experiments, a type-
selective diﬀerence in NP toxicity was observed. A possible
reason for the diﬀerence in uptake and distribution inside the
neural-derived ES cells could be the diﬀerent surface chemistry
of two NPs synthetized, which could improve the endocytosis
mechanisms up to the nucleus in case of Cu0−AuNPs.
Experimental results indicated that the diﬀerences between
Cu0−AuNPs and L1@Cu2+−AuNPs nanoparticles as well as
the target cell type were critical determinants of intracellular
responses and degree of cytotoxicity. At this stage, it was not
possible to completely highlight the mechanism underlying the
diﬀerential toxicity. The evidence emerging from the
experimental results was that apoptosis is the predominant
death pathway for moderate concentrations of NPs in the
solution, whereas necrosis was the predominant pathway for
high concentrations of NPs, according to the data reported in
literature.32,33 Large amount of Cu-based nanoparticles, once
internalized in neurons, caused severe alterations of cell
morphology up to membrane disruption, according to the
images reported in Figure 4 from concentrations of 100 nM
onward. Light concentration of copper NPs inside neuron cells
caused apoptosis as a consequence of oxidative stress induced
by reactive oxygen species associated to metallic nanoparticles.
2.6. Optical Imaging of Cells. Internalization of cells of
the synthesized colloids (Cu0AuNPs and L1@Cu2+AuNPs)
was carried out with a confocal microscope (Horiba
Scientiﬁcs) under bright- and dark-ﬁeld illumination. The
images reported in Figures S3 and S4 are from the treated ES
neuronal cells in diﬀerent areas, the same sample region was
seen in bright-ﬁeld (a) and dark-ﬁeld conditions (b). The dark-
ﬁeld image showed a high density of bright, small scattering
centers dispersed all over the glass slide. The density of these
bright spots clearly showed an eﬀect of concentration addiction
when the colloids were incubated. It appears that the colloids
had a tendency to accumulate inside the cells in the
experimental conditions previously described.17
Figure 4. Cytotoxicity of neural-derived ES cells incubated with
diﬀerent concentrations of Cu0−AuNPs or L1@Cu2+−AuNPs
nanoparticles (0−100−250−1000 nM) for 24 h. Bar = 50 μm.
Figure 5. Confocal ﬂuorescence images of neural-derived ES cells incubated with Cu0−AuNPs or L1@Cu2+−AuNPs (200 μg/mL) for 24 h. Bar =
50 μm.
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3. MATERIALS AND METHODS
All chemicals were of reagent grade or higher and used as
received unless otherwise speciﬁed. Tetrachloroauric acid
(HAuCl4·H2O), CuCl2·6H2O, sodium borohydride (NaBH4),
poly(ethylene glycol)-600 (PEG 600), and phosphate buﬀered
saline (PBS, 0.1 M, pH 7.0, pH 4.0, pH 9.0) were purchased
from Organics and from Aldrich Chemical Co.
3.1. L1 Synthesis. L1 synthesis was based on previous
work that is summarized in Scheme 4. Brieﬂy, starting from
compound 1, the methyl ester of te1pa, the addition of 4-
nitrophenylethyl bromide led to compound 2 with 85% yield.
The speciﬁc reduction of the nitrophenyl was managed with tin
chloride with 83% yield and produced compound 3. A ﬁnal
hydrolysis removed the ester function and generated the
bifunctional cb-te1pa-EtpPhNH2 (compound 4). In the
following sections, the ﬁnal product cb-te1pa-EtpPhNH2 will
be simply called L1.
NMR was performed on Bruker 300 advance spectrometers.
2D NMR 1H−1H homonuclear, 1H−13C heteronuclear
correlations, and homonuclear decoupling experiments were
used for assignment of the 1H and 13C signals. The δ scales are
relative to tetramethylsilane (1H, 13C). The signals are
indicated as follows: chemical shift, intensity, multiplicity (s,
singlet; br s, broad singlet; d, doublet; t, triplet; m, multiplet; q,
quartet), coupling constants J in hertz (Hz). The high
resolution mass spectrometry (HR-MS) analyses were
performed at the Institute of Analytic and Organic Chemistry,
ICOA in Orleans. In details, compound L1 was synthetized by
a three-step procedure, which is reported in the following
section. Results of HR-MS are reported for each step in the
Supporting Information.
3.1.1. Step (i): trans-Di-N-functionalization of Cross-
Bridged Monomethylpicolinate Cyclam (Compound 1)
Yielding Compound 2. 4-Nitrophenylethyl bromide (0.968
g, 4.20 mmol) and potassium carbonate (0.872 g, 6.31 mmol)
were add to a solution of 1 (0.865, 2.10 mmol) in 200 mL of
distilled acetonitrile. The mixture was reﬂuxed overnight. After
the evaporation of the solvent, the crude product was puriﬁed
by column chromatography in silica gel (CHCl3/MeOH 8:2)
to yield compound 2 as a yellow oil (1.000 g, 85%).
3.1.2. Step (ii): Reduction of Compound 2 Yielding
Compound 3. Tin chloride (1.810 g, 9.55 mmol) and
compound 2 (0.500 g, 0.95 mmol) were add to a 40 mL
solution 1:9 of MeOH/HCl aq 12 M. The mixture was stirred
at room temperature overnight and then excess HCl was
neutralized using potassium carbonate. The desired compound
3 was obtained by extraction with chloroform at pH 14 as
yellow oil (420 mg, 83%).
3.1.3. Step (iii): Hydrolysis of Compound 3 Yielding
Compound 4 (L1). Hydrochloric acid (10 mL, 6 M) was
slowly added to compound 3 (0.200 g, 0.38 mmol) and the
mixture was reﬂuxed overnight. After cooling to room
temperature, the solvent was evaporated to yield compound
4 (L1) as an oﬀ-white solid in quantitative yield.
3.2. Synthesis of Cu0−AuNPs. Twenty milliliters of
0.0001 M aqueous HAuCl4 was mixed with 5 mL of CuCl2·
6H20 solution (6.10 × 10
−5 M in water) at room temperature
for 1 h under magnetic stirring to form a Au−Cu blend. Then,
250 μL of poly(ethylene glycol) 600 diacid (PEG) was mixed
to the blend solution under stirring for 2 h. After this time, 3.6
mL of NaBH4 (0.01 M) was added dropwise, followed by rapid
stirring and kept without agitation for 2 h. The color of the
dispersion indeed instantly changed from green-yellow to pink-
red when sodium borohydride was added to a solution of
copper−gold precursor in the presence of the PEG diacid
polymer, with a complete reduction of metal ions conﬁrming
the formation of hybrid nanoparticles in the solution. The as-
prepared Cu0−AuNPs solution was puriﬁed by centrifugation
and dialysis to remove excess of not-conjugated dicarboxylic
PEG.14
3.3. Synthesis of L1@Cu2+−AuNPs. The synthesis of
L1@Cu2+−AuNPs colloids is described here. Twenty milli-
liters of HAuCl4 aqueous solution (2.5 × 10
−4 M in water) was
added to CuCl2 solution (5 mL, 6.10 × 10
−5 M in water)
under stirring for 1 h. After this time, 5 mL of L1 (2.3 × 10−4
M in water) was mixed to this hybrid blend solution during 1
h, and the mixture was stirred at room temperature. At the end
Scheme 4. Synthesis of L1 (cb-te1pa-EtpPhNH2): L1
a
a(i) K2CO3, CH3CN, 12 h, reﬂux, 85%; (ii) tin chloride MeOH/HCl aq 12 M, room temperature, 12 h, 83%; and (iii) hydrochloric acid 6 M,
reﬂux, 12 h, quant.
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of this reaction, 250 μL of dicarboxylic PEG was mixed to the
solution and stirred for 1 h. Finally, 3.6 mL of aqueous 0.01 M
NaBH4 was added at once until stabilization and reduction to
hybrid nanoparticles. The “as-prepared” L1@Cu2+−AuNPs
solution was centrifuged at 5000 rpm for 20 min for three
times and then the supernatant was discarded. This was
repeated twice to remove excess of not-conjugated reagents.
L1@Cu2+−AuNPs were stored at 8 °C and characterized by
UV−vis spectroscopy, transmission electron microscopy, and
Raman spectroscopy.
3.4. Physicochemical Characterization. All the meas-
urements were performed in triplicate to validate the
reproducibility of the synthetic and analytical procedures.15,16
3.4.1. UV−Vis Measurements. Absorption spectra were
recorded using a PerkinElmer Lambda UV/Vis 950
spectrophotometer in plastic cuvettes with an optical path of
10 mm. The wavelength range was 200−900 nm.
3.4.2. Transmission Electron Microscopy (TEM). Size and
morphology of NPs were characterized by transmission
electron microscopy (TEM) (JEM-1011 TEM, Jeol, Inc.,
Peabody, MA) using a Morada CCD camera at an accelerating
voltage of 100 kV.
3.4.3. Raman Spectroscopy. The Raman experiments have
been performed on an Xplora spectrometer (Horiba
Scientiﬁcs-France).15,16
3.4.5. Optical Imaging. The optical images of the cells were
carried out as previously reported.17
3.4.6. Dynamic Light Scattering (DLS). The size measure-
ments were performed using a Zetasizer Nano ZS (Malvern
Instruments, Malvern, U.K.) equipped with a He−Ne laser
(633 nm, ﬁxed scattering angle of 173°) at room temperature.
3.4.7. ζ-Potential Measurements. The ζ-potential of
AuNPs dispersed in water was measured using the electro-
phoretic mode of a Zetasizer Nano ZS (Malvern Instruments
Ltd, U.K.).
3.5. ES Cells Culture Conditions. Embryonic stem cells
(ESCs) can be used as a model system in basic research, drug
discovery, biomedical applications, and nanotechnology
because they combine the potential of unlimited self-renewal
with the ability to diﬀerentiate into a wide range of tissue-
speciﬁc cells. The present study was designed to determine if
the nanoparticles Cu0−AuNPs and L1@Cu2+−AuNPs could
have toxic eﬀects on undiﬀerentiated and neural diﬀerentiated
ES cells. Wild-type mouse AK7 ES cells were maintained in an
undiﬀerentiated state by culture on a monolayer of mitomycin-
C-inactivated ﬁbroblast in the presence of leukemia-inhibiting
factor as previously described.18 At 24 h before treatment, the
cells were seeded on gelatin-coated plates at a density of 4 ×
104 cells/cm2 to allow attachment.
3.5.1. In Vitro Neurons Diﬀerentiation. Neural progenies
can be generated from ESC with high standards of accuracy
and reliability. To induce neural diﬀerentiation, essentially
according to Fico et al.,18 AK7 ES cells at 48 h before inducing
diﬀerentiation were seeded on gelatin-coated plates. At day 0,
the ES cells were dissociated in a single-cell suspension and
1500 cells/cm2 were plated on gelatin-coated plates. The cells
were maintained in diﬀerentiation medium until day 7 when
neural precursors cells were detached using 0.05% trypsin/
ethylenediaminetetraacetic acid solution and frozen in 90%
FBS + 10% dimethyl sulfoxide. Frozen cells were thawed and
immediately plated at 66 000 cells/cm2 in Matrigel-coated
plates. The medium was changed every day until day 13.
3.6. Cell Death Assay. The lethal dose 50 (LD50) is the
amount of a chemical, calculated as the concentration of
chemicals that produces death in 50% of a cellular population.
To determine the lethal dose 50 (LD50) of the nano-
particles Cu0−AuNPs and L1@Cu2+−AuNPs on undiﬀerenti-
ated ES and neural-derived ES cells, these cells were seeded,
respectively, on gelatin-coated or Matrigel-coated plates. The
cells were untreated or treated with diﬀerent concentrations
(0−1000 nM) of Cu0−AuNPs or L1@Cu2+−AuNPs nano-
particles for 24 h, then collected, counted, and analyzed for
their ability to incorporate the cell-permeable dye trypan blue.
Concomitantly, other cells, untreated or treated in the same
way, were visualized by phase-contrast microscopy using the
DMI6000B inverted fully automated microscope with DFC
420 RGB camera (Leica Microsystems, Wetzelar, Germany).
Leica LAS V5.4 software was used for image acquisition/
elaboration (contrast/γ adjusting).
3.7. Immunoﬂuorescence Analysis. For nanoparticles
internalization experiments, neural-diﬀerentiated ESCs were
seeded in six-well plates and cultured for 24 h. Cu0−AuNPs or
L1@Cu2+−AuNPs conjugated with Alexa-Fluor-594, sus-
pended in culture medium at 200 nM, were incubated with
cells for 24 h. After the incubation, the cells were rinsed twice
in PBS to remove the noninternalized nanoparticles, ﬁxed in
4% paraformaldehyde for 30 min, and washed in PBS 1×. After
washing, the cells were incubated with WGA-488 (Invitrogen)
as membrane marker following manufacturer’s instructions.
Nuclei were counterstained with Hoechst 33342 (Invitrogen).
Fluorescent labeling was visualized using the inverted fully
automated confocal Nikon AR-1 microscope. The NIS
elements software was used for image acquisition/elaboration.
4. CONCLUSIONS
Designing hybrid functional nanoparticles for biomedical
applications is still a current challenge in terms of perform-
ances, stability, and safety in biological media. In particular, if
gold nanoparticles are known for their high in vivo inertness
and their use in several applications, including their photo-
physical properties, the use of copper(II) into the hybrid
nanoparticles is still not a trivial task. Once copper is inside the
metallic aggregates, it is usual to obtain unstable and/or
cytotoxic eﬀects coming from the hybrid nanostructure.
The success of this study was then to provide the design, the
synthesis, and the characterization of new potential nano-
complexes based on the incorporation of chelated copper(II)
in gold nanoparticles. Highly thermodynamically stable and
kinetically and electrochemically inert copper(II) chelates have
been used based on a proven cyclam cross-bridged ligand, the
cb-te1pa chelator. Its insertion was facilitated by the presence
of aniline moiety, a carboxylic function, and its overall charge
and proved all along the nanomaterials characterization. In
conclusion, from the results obtained, there is evidence of a
type-selective diﬀerence in NP toxicity in favor of L1@Cu2−
AuNPs. Possible reason to explain nanoparticle-speciﬁc uptake
and distribution inside the neural-derived ES cells may be
attributed to the peculiar features of Cu0−AuNPs or L1@
Cu2−AuNPs nanoparticles. Our results indicated that the
diﬀerences between Cu0−AuNPs or L1@Cu2−AuNPs nano-
particles as well as the target cell type are critical determinants
of intracellular responses and degree of cytotoxicity. These
results allow us to hypothesize that the apoptosis is the
predominant death pathway for moderate concentrations of
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NPs in the solution, whereas necrosis is the predominant
pathway for high concentrations of NPs.
Toxicity comparison with respect to previously reported
results in literature is not straightforward because ES neuron
cells are not very commonly diﬀused in many laboratories;
nevertheless, the synthetized Cu-based NPs showed LD levels
of the same order of those mentioned in critical review study,
recently published.34
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